Medtronic (MDT) Stock Forecast & Price Target

$90.03

+0.71 (+0.79%)

(As of 09/30/2024 ET)

Medtronic - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 15 Analyst Ratings

Sell
1

Hold
9

Buy
5

Based on 15 Wall Street analysts who have issued ratings for Medtronic in the last 12 months, the stock has a consensus rating of "Hold." Out of the 15 analysts, 1 has given a sell rating, 9 have given a hold rating, 4 have given a buy rating, and 1 has given a strong buy rating for MDT.

Consensus Price Target

$92.92
3.21% Upside

According to the 15 analysts' twelve-month price targets for Medtronic, the average price target is $92.92. The highest price target for MDT is $106.00, while the lowest price target for MDT is $83.00. The average price target represents a forecasted upside of 3.21% from the current price of $90.03.

Get the Latest News and Ratings for MDT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Medtronic and its competitors.

MDT Analyst Ratings Over Time

Type	Current Forecast 10/2/23 to 10/1/24	1 Month Ago 9/2/23 to 9/1/24	3 Months Ago 7/4/23 to 7/3/24	1 Year Ago 10/2/22 to 10/2/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	6 Buy rating(s)
Hold	9 Hold rating(s)	9 Hold rating(s)	5 Hold rating(s)	7 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$92.92	$92.92	$91.70	$91.67
Forecasted Upside	3.21% Upside	4.90% Upside	18.80% Upside	17.88% Upside
Consensus Rating	Hold	Hold	Hold	Hold

Protect Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

MDT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MDT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Medtronic Stock vs. The Competition

Type	Medtronic	Medical Companies	S&P 500
Consensus Rating Score	2.33	2.78	2.50
Consensus Rating	Hold	Moderate Buy	Hold
Predicted Upside	3.21% Upside	823.08% Upside	6.15% Upside
News Sentiment Rating	Positive News See Recent MDT News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/23/2024	Daiwa America 0 of 5 stars	R. Department Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/23/2024	Truist Financial 2 of 5 stars		Boost Target	Hold ➝ Hold	$85.00 ➝ $90.00	+2.13%
8/22/2024	Barclays 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$104.00 ➝ $105.00	+19.09%
8/21/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$85.00 ➝ $90.00	+4.41%
8/21/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$105.00 ➝ $106.00	+22.67%
8/21/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Sector Perform ➝ Sector Perform	$92.00 ➝ $92.00	+6.47%
Get the Latest News and Ratings for MDT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.
8/21/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$85.00 ➝ $87.00	+1.90%
8/21/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$82.00 ➝ $90.00	+5.41%
8/21/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$92.00 ➝ $94.00	+10.10%
8/20/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Hold
8/15/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Antalffy Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sell ➝ Neutral	$76.00 ➝ $90.00	+10.12%
7/10/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$90.00 ➝ $85.00	+10.30%
5/30/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Sell	$83.00	+1.84%
2/21/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$95.00 ➝ $98.00	+14.71%
11/22/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$104.00 ➝ $98.00	+24.68%
6/30/2023	22nd Century Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Initiates
6/30/2023	CL King Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$106.00	+22.16%
5/26/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$100.00 ➝ $99.00	+18.51%
2/22/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$80.00 ➝ $87.00	+1.12%
11/23/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$117.00 ➝ $90.00	+13.92%
10/12/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$87.00	+6.24%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 09:29 AM ET.

Should I Buy Medtronic Stock? MDT Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, September 30, 2024. Please send any questions or comments about these Medtronic pros and cons to contact@marketbeat.com.

Medtronic
Bull Case

Here are some ways that investors could benefit from investing in Medtronic plc:

Medtronic plc has consistently shown strong financial performance, with a solid return on equity of 13.68% and a healthy net margin of 12.06%. These indicators reflect the company's profitability and efficiency in utilizing its resources.
Recent analyst ratings have been positive, with multiple firms upgrading their outlook on Medtronic plc, including a "strong-buy" rating from Daiwa America. This positive sentiment from analysts can instill confidence in investors.
Medtronic plc has a stable dividend payout, currently offering a dividend yield of 3.13%. This can be attractive to income-oriented investors looking for consistent returns.
The company's stock price has been trading at a relatively high level, indicating market confidence in Medtronic plc's future prospects. As of the latest trading session, the stock was valued at $89.34, reflecting investor interest.
Medtronic plc's diverse portfolio of device-based medical therapies positions it well in the healthcare industry, providing a range of products that cater to different healthcare needs. This diversification can help mitigate risks associated with relying on a single product line.

Medtronic
Bear Case

Investors should be bearish about investing in Medtronic plc for these reasons:

Despite positive analyst ratings, there have been some neutral and sell ratings on Medtronic plc, indicating varying opinions on the company's future performance. Investors should consider the mixed outlook from different analysts.
Medtronic plc's stock price has experienced fluctuations in recent trading sessions, which may introduce volatility and uncertainty for investors. Market fluctuations can impact the stock's value and investor returns.
The company operates in the healthcare sector, which is subject to regulatory changes, competitive pressures, and technological advancements. These external factors can influence Medtronic plc's operations and financial results.
Medtronic plc's debt-to-equity ratio of 0.55 indicates a moderate level of leverage, which can pose risks during economic downturns or periods of financial instability. Investors should assess the company's debt management strategies.
While Medtronic plc has a history of revenue growth, the company's P/E ratio of 32.49 and P/E/G ratio of 2.57 suggest that the stock may be trading at a premium valuation. Investors should evaluate whether the current stock price reflects the company's growth potential.

MDT Forecast - Frequently Asked Questions

: According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Medtronic is $92.92, with a high forecast of $106.00 and a low forecast of $83.00.
: 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There is currently 1 sell rating, 9 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares.
: According to analysts, Medtronic's stock has a predicted upside of 3.21% based on their 12-month stock forecasts.
: Over the previous 90 days, Medtronic's stock had 2 upgrades and 1 downgrade by analysts.
: Medtronic has been rated by research analysts at Barclays, Citigroup, Daiwa America, Needham & Company LLC, Oppenheimer, Piper Sandler, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, Truist Financial, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Medtronic less than other "medical" companies. The consensus rating for Medtronic is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MDT compares to other companies.

Stock Forecasts and Research Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Retire off just one stock ticker? (Ad)

ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT make you rich. However, there is one stock that stands head and shoulders above everything else. It's currently trading for only $15...

Click here for the ticker >>>

This page (NYSE:MDT) was last updated on 10/1/2024 by MarketBeat.com Staff

From Our Partners